Nationwide Research on the Rewilding of Kindergarten Yards
- Conditions
- Cognitive ChangeMicrobial ColonizationAsthma in ChildrenAllergyAtopic DermatitisRespiratory InfectionNature, Human
- Registration Number
- NCT06390878
- Lead Sponsor
- Natural Resources Institute Finland
- Brief Summary
Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities that is associated with altered commensal microbiota and a rising burden of immunological disorders among urban children.
The investigators will estimate how rewilding of kindergarten yards affects commensal microbiome, prevalence of allergies, asthma, atopic dermatitis and infections, cortisol levels, cognitive skills and plasma cytokine levels of children.
Our specific aims are:
To assess if rewilding diversifies health-associated skin, saliva and gut microbiota and reduces infectious diseases and atopic or allergic symptoms.
Assess whether the rewilding has positive effects on cognitive skills. Assess whether the rewilding changes cortisol and plasma cytokine levels. The investigators will recruit altogether 320 (160 per treatment) study subjects aged between 1-5 to questionnaire study (Task 2), from which 120 study subjects will be analyzed more detailed using microbiological and blood samples (Task 1).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 320
- Attendance in kindergarten
- Use of antibiotics in the year before sampling
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Skin Gammaproteobacteria Baseline, 3 month, 1 year, 2 year, 3 year Difference on skin gammaproteobacterial diversity between rewilding and control group
- Secondary Outcome Measures
Name Time Method Difference in taxonomies of skin, saliva and stool microbiota Baseline, 3 month, 1 year, 2 year, 3 year It will be analyzed if microbial communities are different between treatments
White blood cell distribution Baseline, 3 month, 1 year, 2 year, 3 year It will be analyzed if the distribution is different between treatments
Cortisol levels Baseline, 3 month, 1 year, 2 year, 3 year Cortisol levels measured from hair samples
Microbial observed species richness Baseline, 3 month, 1 year, 2 year, 3 year Higher score in observed species richness of commensal microbiota among biodiversity treatment
Infectious diseases Baseline, 3 month, 1 year, 2 year, 3 year Infections will be recorded with questionnaires.
Asthma symptoms Baseline, 3 month, 1 year, 2 year, 3 year Asthma symptoms will be recorded with questionnaires.
Allergy Baseline, 3 month, 1 year, 2 year, 3 year Allergies will be recorded with questionnaires.
Patient-oriented Eczema Measure Baseline, 3 month, 1 year, 2 year, 3 year Lower score on patient-oriented Eczema Measure among intervention treatment compared to control that indicates lower eczema among intervention treatment. Minimum 0, maximum 28.
White blood cell transcriptomics Baseline, 3 month, 1 year, 2 year, 3 year White blood cell transcriptome is analyzed with single cell RNA sequencing.
Skin cytokines Baseline, 3 month, 1 year, 2 year, 3 year Cytokines will be analyzed using skin tape strip samples.
Difference in diversity of skin, saliva and stool microbiota Baseline, 3 month, 1 year, 2 year, 3 year It will be analyzed if microbial communities are different between treatments
Atopic dermatitis Baseline, 3 month, 1 year, 2 year, 3 year Atopic dermatitis will be recorded with questionnaires.
Plasma cytokines Baseline, 3 month, 1 year, 2 year, 3 year Cytokines will be analyzed analyzed with Meso Scale.
Wechsler Preschool and Primary Scale of Intelligence Baseline, 3 month, 1 year, 2 year, 3 year Higher score on Wechsler Preschool and Primary Scale of Intelligence among intervention treatment compared to control that indicates better cognitive skills among intervention treatment. Minimum 40, maximum 170.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Natural Resources Institute Finland
🇫🇮Helsinki, Uusimaa, Finland
Tampere University
🇫🇮Tampere, Finland
Natural Resources Institute Finland🇫🇮Helsinki, Uusimaa, FinlandMarja RoslundContact+358295322256marja.roslund@luke.fi